Clinical trial
Study to Assess the Efficacy and Safety of Dysport® in Cervical Dystonia
NCT00447772 · Ipsen, Industry · Completed
Key facts
| NCT number | NCT00447772 |
|---|---|
| Title | Study to Assess the Efficacy and Safety of Dysport® in Cervical Dystonia |
| Official title | Multicentre Open Study on the Efficacy and Safety of Botulinum Toxin A (500 Units Dysport®) in the Treatment of Heterogeneous Forms of Cervical Dystonia |
| Lead sponsor | Ipsen, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cervical Dystonia |
| Intervention type | Biological |
| Interventions | Botulinum toxin type A |
| Enrollment | 516 |
| Start date | Oct 1, 2004 |
| Primary completion | Feb 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Mar 15, 2007 |
| Last update posted | Mar 30, 2023 |
| Countries | Austria, Germany |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: